Series date: 
01/01/2024 - 12:00am CST to 12/31/2024 - 11:59pm CST

Course Director:
Mouhammed Rihawi, MD
Overall Objectives:

  1. Identify current evidence-based practices to provide improved outcomes for patients with ILD.
  2. Apply treatment plans agreed upon by consensus at the conference to their ILD patients.
  3. Expand their knowledge base in ILD management due to interaction with colleagues and will share perspective, expertise, and experience.
  4. Recognize available resources that the patient may be eligible for.

Target Audience:  
Pulmonary Medicine MD, Chest Radiologist MD, Pathologist, MD, Rheumatologist MD, Staff RN, Clinic RN, ILD pharmaceutical NP coordinators.

Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Medical Association (AMA) 
Advocate Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Contact Information:
Leah Del Gaudio, NP :

Series location: 
ASLMC Vince Lombardi Cancer Center Conference Room
Milwaukee, WI
United States